IROBOT CORP (IRBT)
US4627261005 - Common Stock
Overall IRBT gets a fundamental rating of 1 out of 10. We evaluated IRBT against 64 industry peers in the Household Durables industry. IRBT has a bad profitability rating. Also its financial health evaluation is rather negative. IRBT does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
IRBT had negative earnings in the past year.
IRBT had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: IRBT reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: IRBT reported negative operating cash flow in multiple years.
1.2 Ratios
With a Return On Assets value of -19.70%, IRBT is not doing good in the industry: 90.32% of the companies in the same industry are doing better.
IRBT has a worse Return On Equity (-87.91%) than 91.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.7% | ||
| ROE | -87.91% | ||
| ROIC | N/A |
ROA(3y)-24.41%
ROA(5y)-10.32%
ROE(3y)-70.34%
ROE(5y)-35.93%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IRBT's Gross Margin of 22.52% is on the low side compared to the rest of the industry. IRBT is outperformed by 72.58% of its industry peers.
In the last couple of years the Gross Margin of IRBT has declined.
The Profit Margin and Operating Margin are not available for IRBT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.52% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.24%
GM growth 5Y-15.4%
2. Health
2.1 Basic Checks
IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
IRBT has more shares outstanding than it did 1 year ago.
IRBT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for IRBT is higher compared to a year ago.
2.2 Solvency
IRBT has an Altman-Z score of 0.97. This is a bad value and indicates that IRBT is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of IRBT (0.97) is worse than 87.10% of its industry peers.
A Debt/Equity ratio of 1.24 is on the high side and indicates that IRBT has dependencies on debt financing.
IRBT has a Debt to Equity ratio of 1.24. This is in the lower half of the industry: IRBT underperforms 77.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.97 |
ROIC/WACCN/A
WACC9.11%
2.3 Liquidity
A Current Ratio of 1.45 indicates that IRBT should not have too much problems paying its short term obligations.
IRBT has a worse Current ratio (1.45) than 82.26% of its industry peers.
IRBT has a Quick Ratio of 1.45. This is a bad value and indicates that IRBT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.94, IRBT perfoms like the industry average, outperforming 45.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.45 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.94% over the past year.
The Revenue for IRBT has decreased by -13.14% in the past year. This is quite bad
Measured over the past years, IRBT shows a decrease in Revenue. The Revenue has been decreasing by -4.01% on average per year.
EPS 1Y (TTM)28.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%101.06%
Revenue 1Y (TTM)-13.14%
Revenue growth 3Y-14.61%
Revenue growth 5Y-4.01%
Sales Q2Q%3.9%
3.2 Future
IRBT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.64% yearly.
The Revenue is expected to decrease by -0.06% on average over the next years.
EPS Next Y52.6%
EPS Next 2Y34.85%
EPS Next 3Y22.64%
EPS Next 5YN/A
Revenue Next Year-21.7%
Revenue Next 2Y-11.86%
Revenue Next 3Y-0.06%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
IRBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IRBT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
IRBT's earnings are expected to grow with 22.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.85%
EPS Next 3Y22.64%
5. Dividend
5.1 Amount
No dividends for IRBT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
IROBOT CORP
NASDAQ:IRBT (11/15/2024, 8:19:07 PM)
After market: 6.28 +0.07 (+1.13%)6.21
-0.17 (-2.66%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap189.78M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.7% | ||
| ROE | -87.91% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.52% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.45 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)28.94%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y52.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.14%
Revenue growth 3Y-14.61%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y